Synergizing Software and Hardware Capabilities: Driving AI × GMP × Digital Twin to Accelerate the Implementation of Smart Manufacturing in Biopharmaceuticals TherapiAI, an AI-driven pharmaceutical technology company, announced yesterday (the 21st) the official signing of a strategic partnership Memorandum of
Continue Reading
Google and Japan’s Chiral Share the Stage to Co-Envision the Next Decade of Biopharma TherapiAI, a pioneering biotech AI startup, hosted the “AI-Driven Future of Biopharma: From R&D Innovation to Digital Twin” seminar today (7th) at the Taipei Bioinnovation Park.
Continue Reading
TherapiAI, a leading force in AI-driven drug discovery, officially announced today (the 22nd) its strategic expansion into the Japanese market through a formal partnership with Chiral, an emerging Japanese AI scientific computing startup. This collaboration marks a significant milestone in
Continue Reading
Cracking the ‘Black Box’ of Cell Manufacturing for the First Time ! TherapiAI, a leading AI-powered biopharmaceutical innovator, today announced its latest research collaboration with Dr. Kun-Yi Lin, a prominent stem cell expert from Tri-Service General Hospital. The study, recently
Continue Reading
Leading AI pharmaceutical brand TherapiAI is expanding its footprint in Asia! Following a successful entry into the Japanese market, TherapiAI officially launched its strategic expansion into Southeast Asia today (the 24th). The company recently made its regional debut by unveiling
Continue Reading
Bora to discuss a recent collaboration with Therapi AI, highlighting its focus on strengthening operational execution across the biopharma development cycle and supply chain through AI-enabled technologies Bora Pharmaceuticals (TWSE: 6472; OTCQX: BORAY) operates with a differentiated “dual-engine” strategy, combining
Continue Reading
Article Categories
Article Categories
Article Categories
Latest Articles
Follow Us
